Implementing an optimized glucose-lowering strategy with a novel once daily modified release gliclazide formulation

In this large, real world study, progressive uptitration with gliclazide MR 60 mg once daily appears to be efficacious and safe in individuals with suboptimal glycemic control at various stages of the diabetes continuum.